Novo Nordisk to Buy Inversago Pharma for Up to $1.1 Billion

Wegovy maker Novo Nordisk A/S agreed to buy Inversago Pharma, a maker of experimental obesity and diabetes treatments, for as much as $1.08 billion. #press

https://www.bloomberg.com/news/articles/2023-08-10/novo-nordisk-to-buy-inversago-pharma-for-up-to-1-1-billion?utm_source=press.coop